Penicillin allergy delabelling of patients at risk of sexually transmitted infections in primary care
Date Added:
March 30, 2023
Journal/Publication:
Canadian Medical Association Journal
Publisher:
CMA Impact
Publication Date:
March 27, 2023
Issue:
12
Volume:
195
Pages:
E449-E451
Type:
Meta-analyses, Reviews, and Guidelines
Format:
Article
DOI (1):
10.1503/cmaj.221266
PMID (1):
36972911
Abstract
KEY POINTS
Most patients who report a penicillin allergy do not have a serious allergy.
Penicillin allergy delabelling enables patients to receive penicillin and β-lactam antibiotics when indicated.
A simple algorithm allows for stratification of allergy risk for patients.
Patients at low risk of a serious allergic reaction can undergo an oral penicillin challenge in sexual health clinics and other primary care settings.
Text Availability
Free full text
RPR Commentary
A concise review and algorithm for evaluating and delabelling "penicillin-allergic"
patients. James W. Mold, MD, MPH